N

New Hope Research Development | Corona, CA

Research site

(Unclaimed)

Location

900 S. Main St. Suite 201, Corona, California, United States of America

Site insights

Top conditions

Top treatments

Contezolid

LY3298176

Contezolid Acefosamil

APL-1401

Deudomperidone

Tirzepatide

CIN-102

Linezolid

Parent organization

This site is a part of New Hope Research Development

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 4 total trials

A Phase 1b Study to Evaluate APL-1401 in Patients With Moderately to Severely Active Ulcerative Colitis

This is a randomized, double-blind, placebo-controlled, phase 1b study designed to evaluate safety, tolerability, PK, and preliminary efficacy of APL...

Enrolling

Ulcerative Colitis

Drug: Placebo

Drug: APL-1401

Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)

This is a Phase 3, multicenter, randomized, double-blind, safety and efficacy study of contezolid acefosamil (IV)/contezolid (PO) compared with linez...

Enrolling

Diabetic Foot Infection

Drug: contezolid acefosamil (IV)/contezolid (PO)

Drug: Linezolid (IV and PO)

Trial sponsors

A

C

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms